Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03045328
Title Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Steven E. Coutre
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford University, School of Medicine Stanford California 94305 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field